A popular theory frequently utilized by technical analysts suggests U.S. stocks could be headed for one last leg higher over ...

Oppenheimer maintained its Outperform rating on AppLovin (APP) while highlighting key points for the company from the ...

Christopher Nolan’s Oppenheimer was that rare movie that was both a box office hit and a serious award winner. It also had ...

The director of ‘The End’ discusses getting tips from Werner Herzog and how contemplating catastrophe can make us more human ...

Fintel reports that on March 27, 2025, Oppenheimer initiated coverage of Aurora Innovation (NasdaqGS:AUR) with a Outperform ...

Fintel reports that on March 27, 2025, Oppenheimer initiated coverage of Ouster (NasdaqGS:OUST) with a Outperform ...

Oppenheimer was rightly lauded for his only two previous features, hybrid documentaries The Act of Killing (regularly in ...

As previously reported, Oppenheimer initiated coverage of Ouster (OUST) with an Outperform rating and $16 price target The firm sees Ouster as ...

Oppenheimer called the expected M&A rebound under the Trump administration “delayed or cancelled” and downgraded to "perform" ...

Written and Directed by Joshua Oppenheimer. Starring Tilda Swinton, George MacKay, Moses Ingram, Michael Shannon, Bronagh ...

Jim Cramer voiced skepticism about Lululemon Athletica Inc.'s latest earnings, posting on X, "I don't know how LULU could be ...

Oppenheimer said on Wednesday it no longer expects growth in U.S. investment banking revenue this year and slashed its ...